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Edited by K. MorikawaAbstractFatty acid biosynthesis is an essential component of metabolism in both eukaryotes and prokaryotes. The
fatty acid biosynthetic pathway of Gram-negative bacteria is an established therapeutic target. Two
homologous enzymes FabA and FabZ catalyze a key step in fatty acid biosynthesis; both dehydrate
hydroxyacyl fatty acids that are coupled via a phosphopantetheine to an acyl carrier protein (ACP). The
resulting trans-2-enoyl-ACP is further polymerized in a processive manner. FabA, however, carries out a
second reaction involving isomerization of trans-2-enoyl fatty acid to cis-3-enoyl fatty acid. We have solved the
structure of Pseudomonas aeruginosa FabA with a substrate allowing detailed molecular insight into the
interactions of the active site. This has allowed a detailed examination of the factors governing the second
catalytic step. We have also determined the structure of FabA in complex with small molecules (so-called
fragments). These small molecules occupy distinct regions of the active site and form the basis for a rational
inhibitor design program.
© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license. Introduction
In bacteria, plants and parasites, the synthesis of
fatty acids is the result of the type II fatty acid
synthetic system (often denoted FAS II). In contrast
to the FAS I found in mammals, the FAS II pathway
utilizes separate enzymes that catalyze the individual
steps rather than a large multiprotein complex (for
review, see Ref. 1). In the Gram-negative bacteria,
two enzymes, FabA and FabB, are responsible for
the production of unsaturated fatty acids. Unsaturat-
ed fatty acids are essential to the cells because it is
the ratio of saturated/unsaturated fatty acids that
controls the physical properties of the membrane.2
The essential nature of unsaturated fatty acids has
been demonstrated by making FabA (or FabB)
deletion Pseudomonas aeruginosa mutant strains.
The mutant strains are auxotrophic for unsaturated
fatty acids under anaerobic conditions.3,40022-2836 © 2012 Elsevier Ltd. Open access under CC BY-NC-ND liceFabA is a bifunctional enzyme that catalyzes the
dehydration of hydroxyacyl-acyl carrier protein (ACP)
to the trans-2-enoyl-ACP (Fig. 1a). This step is also
catalyzedby the homologousFabZenzyme.Uniquely,
FabA can perform a second reaction, the isomeriza-
tion of the double bond to a cis-3-decenoyl-ACP,
although the cis product is formed only in small
amounts. FabB specifically elongates this cis-unsat-
urated fatty acid in a process separate from the
classic FAS II pathway. The trans fatty acid produced
by both FabA and FabZ is reduced and subsequently
elongated in the classic FAS II pathway.
Both FabA and FabZ have two principal catalytic
residues, a His from one subunit and a carboxylic
acid (Asp in FabA and Glu in FabZ) from the other.
Although initial predictions suggested that the ability
to catalyze the second step was related to the
presence of Asp or Glu, a combined structural and
functional study of FabZ of P. aeruginosa and FabAJ. Mol. Biol. (2013) 425, 365–377nse. 
Fig. 1. Ligands of FabA. (a) Catalytic reaction of β-hydroxyacyl-ACP dehydratase; both FabA and FabZ catalyze the
first reaction (dehydration) but only FabA catalyzes the second (isomerization). The chemical structure of the
phosphopantetheine, the prosthetic group of ACP, is detailed. (b) Chemical structures of 3-hydroxydecanoyl-NAC that
mimics the ACP substrate, PfFabZ inhibitor NAS91 and PaFabA binding fragments. The dashed boxes highlight the
portion of the phosphopantetheine moiety mimicked by NAC. (c) Overall structure of PaFabA monomer. The secondary
structure elements are labeled; the two catalytic residues (H70 and D84) and the last phenylalanine (F171) have been
added in stick (carbon atoms colored green, oxygen atoms colored red and nitrogen atoms colored blue).
366 Mechanism of P. aeruginosa Protein Dehydrataseof Escherichia coli demonstrated that the catalytic
properties of the two enzymes are not related to a
simple Asp/Glu switch. Rather, it was the shape of
the substrate-binding pocket that underpinned the
regioselectivity of the enzyme.5,6 A structure of
EcFabA covalently bound (through the catalytic His
residue) to the suicide inhibitor 2-decenoyl-N-acet-
ylcysteamine (NAC) has been reported, but theinhibitor binds with a different stereochemistry than
either substrates or products.7 No structure of either
FabA or FabZ in complex with a correctly configured
substrate or substrate mimic has been reported, and
this has hindered a full molecular understanding of
the mechanism.
The increase in prevalence of antibiotic-resistant
bacteria has meant that bacteria have re-emerged
367Mechanism of P. aeruginosa Protein Dehydrataseas a significant problem in the developed world. It is
generally accepted that there is a requirement for
new drug starting points for novel targets. The
significant differences between the human FAS I
system and the type II system of bacteria, coupled
to the essentiality of fatty acids in bacteria, have
long made the type II pathway an antibacterial
target.8–10 Fragment-based approaches to devise
new synthetic starting points for inhibitor design
have become widely used in the pharmaceutical
sector.11,12 Fragment-based approaches rely on the
identification of compounds that bind at the active
site. Crucially, the compounds are synthetically
simple; thus, they can be elaborated more easily
than traditional drug starting points. Often, such
fragments have very weak binding and, as a result
of this, biophysical methods (e.g., NMR and
crystallography) rather than assay screening are
required to identify them.
We report the X-ray structure of the wild type of
FabA of P. aeruginosa in the free form, in complex
with four potential inhibitor starting points (so-called
fragments) and the H70N mutant in complex with a
substrate analogue: 3-hydroxydecanoyl-NAC. This
first structure of a β-hydroxyacyl-ACP dehydratase in
complex with a correctly configured synthetic sub-
strate analogue rationalizes at a molecular level the
catalytic mechanism of this bifunctional mechanism.Results
Overall structure of PaFabA
The crystal structure of the 171 residues ofPaFabA
has been solved to a resolution of 2 Å. Residues
2–133 and 138–171 are well ordered. The monomer
adopts the α+β “hotdog” fold previously described
for the structure of E. coli FabA (EcFabA),7 a six-
stranded antiparallel β-sheet wrapped around a long
hydrophobic α-helix (α3) (Fig. 1c). Two other helices
are also present on the structure: α-helix (α1) at the
N-terminus and one small 310 helix between β2 and
β3 (α2). PaFabA superposes with an rmsd of 0.58 for
166 Cα atoms to EcFabA (68% sequence identity)7
and an rmsd of 1.53 for 135 Cα to PaFabZ5 (31%
identity for 133 residues).
In the native crystal, the only major differences
between the 10 molecules of the asymmetric unit are
in the C-terminal region. In chains B and E–J,
interactions between Thr166 and Asp169 stabilize a
type I turn, while in chains A, C and D, residues 165–
168 form a type VIII turn (Fig. S2a). Despite this, the
side chain of the terminal phenylalanine (Phe171)
occupies approximately the same spatial position
relative to the rest of structure and is stabilized by
van der Waals interactions with Phe165 and Leu106.
In effect, it acts as a “door” separating the active sitefrom the ACP-binding groove (Arg104, Leu106,
Gly107, Leu140, Gly163 and Phe165 from onemono-
mer; Lys112, Phe114 and Ile134 from the other one).
The same residue is found in EcFabA, and although
a different residue plays this role in FabZ proteins
(Tyr88 in PaFabZ or CjFabZ and Tyr100 in HpFabZ),
the function is a conserved feature of the β-
hydroxyacyl-ACP dehydratase family. For the activity
of the protein, the C-terminal region needs to be
flexible to allow access to the active site for the acyl-
ACP substrate. The differences observed in the
crystal may reflect this flexibility, as this region is
also involved in the crystal packing, making it difficult
to assign functional significance to these changes.
The gel-filtration profile and crystal interfaces anal-
ysis (PISA13) confirm that the enzyme is a dimer
(Fig. 2a). The two active-site residues (His70 and
Asp84) have been confirmed by the observed loss of
activity in the mutants H70N, D84N and H70N D84N.
Binding of 3-hydroxydecanoyl-NAC in the
H70N PaFabA
There are five monomers in the asymmetric unit;
however, as they are essentially the same, we will
describe only the most well ordered monomer (chain
D) and its dimer with monomer C. The six C-terminal
residues adopt a position similar to the conformation
of chains A, C and D of the free structure (Fig. S2b).
The rotamer of Phe171 adjusts due to contacts with
the 3-hydroxydecanoyl-NAC, but it still blocks
solvent access through the tunnel to the catalytic
residues (Fig. S2b). 3-Hydroxydecanoyl-NAC is
bound at the active site and makes contacts with
both proteins in the dimer (Fig. 2a and b). The NAC
group binds in the pantetheine tunnel, where it
mimics the binding of pantetheine (Fig. 1). The
pantetheine tunnel is formed by β3 of chain C and
the loops between α2–α3 and β3–β4 from chain D.
The NAC moiety makes hydrogen bonds to the
carbonyl of Ala105 of chain C, and through a water
molecule, it bridges to Met77, Val117 and Tyr155
from the other subunit (Fig. 2b and c).
The carbonyl of the thioester (C1) makes a
hydrogen bond with NH of Ala105 of β3. Carbons
C1–C4 of the 3-hydroxydecanoyl-NAC bind close to
the catalytic residues Asp84 of the chain C and
H70N from the chain D. The β-hydroxy interacts with
the carboxylic group of Asp84 and a water molecule
(denoted W1), which is hydrogen bonded to the
amides of Cys80 and Gly79 from the other monomer
(as well as to Asp84 from chain C). This water
molecule is over 4 Å from H70 and conserved in the
apostructure of FabA and FabZ. It had been
proposed to occupy the position of the water
eliminated from substrate.5 The H70Nmutation itself
does not appear to change the protein structure or
the arrangement of active-site residues; the side-
chain atoms of Asn overlap with atoms of the His
Fig. 2 (legend on next page)
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369Mechanism of P. aeruginosa Protein Dehydrataseside chain in the native structure (Fig. S3). The amide
of the Asn side chain makes the same hydrogen
bond to the carbonyl of Val76 as does Nδ1 of His70 in
the wild type. Phe71 and Pro78 that stack against the
imidazole ring of H70 are unchanged in the mutant,
and the characteristic non-proline cis-peptide (resi-
dues 70–71) is preserved. Perhaps surprisingly,
given its previously proposed role, W1 is unchanged
in location or hydrogen bonding in the complex,
except that it has an additional hydrogen bond, the
3-OH of the substrate mimic. SinceW1 is beyond the
normal range of van der Waals interactions with H70,
we do not think that its preservation in the complex is
a consequence of the H70N mutation. In the
complex, there is an additional water molecule (Fig.
S3) (which we denote W3), which may be present as
a result of the mutation, but it only hydrogen bonds
with W1 and D84 as well as H70N. We have made a
model of the wild-type enzyme complex by simply
changing H70N back to histidine. As a result, the Nε
of the histidine points directly to the C2 atom of the
substrate mimic (Fig. 2c).
The aliphatic tail of 3-hydroxydecanoyl-NAC is
embedded in a deep hydrophobic tunnel that is
formed by α3, β3 and the loop connecting α1–β1.
C4–C10 atoms of the lipid sit parallel with the α3
helix. A comparison of this complex with the covalent
EcFabA 2-decenoyl-NAC complex shows several
differences (Fig. S4). The covalent bond between C3
of the 2-decenoyl-NAC and His70 results in the NAC
group being pushed further along the groove away
from the active site while the aliphatic tail is pulled in
toward the active site relative to the complex
described here. Consequently, the critical C1–C4
atoms of the lipid that undergo chemical transfor-
mation are misaligned between the two structures
(Fig. S4). As a result, the interactions between the
catalytic residues and the lipids are very different.
Comparison of PaFabA and PaFabZ
As expected, PaFabA and PaFabZ adopt the
same fold. The β-sheet of the two proteins super-Fig. 2. Structural biology of FabA. (a) Overall structure of Pa
key catalytic residues (H70 and D84) come from different mon
and the 3-hydroxydecanoyl-NAC are shown in stick. The three
the catalytic region and the alkyl-binding pocket, have been in
around the 3-hydroxydecanoyl-NAC in complex with PaFabA H
(yellow) and the active-site residues of PaFabA with His70
Residues within 4.0 Å of the fragments are displayed, and hy
catalytic residues are correctly positioned for proton transfer, re
binding tunnel is highlighted by a box and an arrow. (d) Su
PaFabA complex (carbons shown as yellow stick) onto PaFab
active site are colored pale orange and pale pink) does not
catalyzing the dehydration reaction. The differences in the al
carbons C5–C8 (black box) of substrate and PaFabZ. The cat
green. (e) Surfaces of the active site of PaFabZ (red) and PaFa
3-hydroxydecanoyl-NAC have been shown in teal. Amino acid
drawn in stick.poses quite well; however, the helix α1, the end of
the strand β1, the beginning of the strand β3 and the
orientation of helix α3 are shifted. The positions of
loops α1–β1, β1–β2, α3–β3 and β4–β5 are different
due to sequence insertions in the PaFabA protein
(Fig. S1). Comparison of the structure around the
active site shows that the pantetheine-binding tunnel
is similar. In the catalytic region, the histidines (70
and 49 for PaFabA and PaFabZ, respectively) are
essentially in the same position but a glutamate
replaces the aspartate in FabZ proteins. However, a
compensating shift in helix α3 (which moves away
from the active site in PaFabZ) means that the net
shift in the relative positions of the carboxylate
groups is very small (approximately 1.2 Å) (Fig. 2d
and Fig. S5), consistent with the previous observa-
tion that the Glu/Asp substitution has no effect on the
catalytic ability.5 Two residues adjacent to the
catalytic machinery, Ala66 and Phe89 of PaFabZ,
are replaced in PaFabA by Trp87 and Ala105,
respectively. The double mutation can be seen as
partially compensating in that the phenyl ring in
PaFabZ overlaps with the indole of Trp87 PaFabA
(despite the side chains coming from different
regions of structure).
As outlined first by Kimber et al., there are major
differences in the alkyl-binding pocket that are
clearly visualized by this new complex of PaFabA.5
Around the C4 and C5 atoms, in PaFabA, the
distance between Pro29 and Arg104 on opposite
sides of the active site is over 10 Å, whereas in
PaFabZ, His13 and Tyr88 are 7.8 Å apart. The main
chain of Tyr87 in PaFabZ is displaced into the active
site such that it would clash with C6 and C7 of the
ligand (Fig. 2d and e). These changes are a result of
differences in the loop structures connecting α1–β1
and α3–β3 in the two proteins. In all FabA proteins,
the α1–β1 loop is conserved and is larger than
observed in FabZ sequences. In the FabA structures
(both PaFabA and EcFabA), this loop contributes
extensively to the alkyl-binding tunnel while the
conserved α3–β3 (shorter than FabZ sequences)
plays a minor role. In FabZ, the larger α3–β3 loopFabA dimer. The active site is formed by the dimer; the two
omers that form the dimer. The C-terminal phenylalanine
regions of the active site, the pantetheine-binding tunnel,
dicated by boxes. (b) Final 2Fo−Fc electron density at 1 σ
70N. (c) Interactions between the 3-hydroxydecanoyl-NAC
modeled (experimental structure has H70N mutation).
drogen bonds are shown as black broken lines. The two
presented by sand-colored broken lines. The pantetheine-
perposition of C1–C4 portion of 3-hydroxydecanoyl-NAC
Z (carbons from the two monomers that form the PaFabZ
give any clashes and would give a complex capable of
kyl-binding pocket would, however, result in clashes with
alytic residues of PaFabA are shown with carbons colored
bA (light blue) have been represented. The carbons of the
s of PaFabZ that narrow the alkyl tunnel (H13 and Y87) are
370 Mechanism of P. aeruginosa Protein Dehydratasecontributes extensively to the alkyl-binding tunnel
and the shorter α1–β1 plays only a minor role.
These changes are accompanied by a shift of the
N-terminus ofβ3 that shifts into the alkyl-binding tunnel
in PaFabZ when compared to PaFabA (Fig. S5).
Discovery of binding fragments
A screen of 436 compounds from the Maybridge
Ro3 500 fragments library was conducted using
saturated transfer difference and water logsy NMR
techniques. We identified 39 fragments as potential-
ly binding to PaFabA, and we have been able to
obtain three co-complexes (Fig. S6a–c). 5-(2-Thie-
nyl)-3-isoxazolyl methanol (fragment 1) binds in the
pantetheine-binding tunnel occluding it (Fig. 3a and
Fig. S6d). The thienyl group displaces the C-terminal
Phe171 residue and makes extensive van der Waals
interactions. The displacement of Phe171 results in
a rearrangement of six C-terminal residues (Fig.
S2c). The isoxazolyl ring interacts with the protein
via a conserved water molecule, and the methanol
group hydrogen bonds to NH of Gly79. 3-(Pyridin-2-
yloxy)aniline (fragment 2) binds at the catalytic site
(Fig. 3b and Fig. S6e), the pyridine ring overlappingFig. 3. Crystal structures of PaFabA complexes with differen
(c) and 4 (d) with PaFabA are shown. Residues within 4.0 Å of
figures has been made to allow visualization of the interac
Fragments 2 and 3 bind at the catalytic region while fragmen
superposition shows that the four fragments occupy different pwith the methanol of fragment 1. The N atom of the
pyridine ring forms a hydrogen bond with Ala105,
and the aniline ring fills the C4 to C6 substrate
binding pocket of the protein. The amide group
points into the empty hydrophobic tunnel. Gln88
adopts a second partially occupied conformer, which
results in contacts with the aniline ring. 3-(Pen-
tylthio)-4H-1,2,4-triazole (fragment 3) is quite similar
to the substrate and overlaps with fragment 2. The
triazole ring occupies the same space as the
pyridine ring of fragment 2 and makes a bidentate
hydrogen bond to Ala105 (Fig. 3c and d and Fig.
S6f). The hydrophobic tail reaches into the hydro-
phobic alkyl chain tunnel. The thioether group does
not displace the water molecule bound to Asp84.
This fragment complex was obtained by soaking,
and the density is less well ordered than the other
two. Fragment 4, the N-isobutyl-2-([5-(2-thienyl)-1,2-
oxazol-3-yl]methoxy)acetamide, has been identified
by virtual screening based on fragment 1. In the
crystal structure, one molecule binds in the pan-
tetheine-binding tunnel of monomer B (Fig. 3d). The
thienyl and the oxazole rings have reversed com-
pared to fragment 1, and the N-isobutyl-acetamide
group extends to the ACP-binding groove, making at fragments. Interactions between fragments 1 (a), 2 (b), 3
the fragments are displayed. A change in orientation of the
tions between the fragments and enzyme more clearly.
ts 1 and 4 occlude the pantetheine-binding tunnel (e). A
ortions of the binding site.
g. 4. Isothermal calorimetry titration of fragments 1 (a), 2 (b) and 3 (c) with PaFabA. Upper panel: raw titration data. Low panel: integrated and dilution corrected
p areas of the raw data. Data were fitted with a single-binding-site model to evaluate the dissociation constant (Kd).
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372 Mechanism of P. aeruginosa Protein Dehydratasehydrogen bond with the main chain of Phe113.
Analysis of the binding of the fragments by isother-
mal titration calorimetry shows a binding constant of
around 10 mM for fragments 1 and 3 and 0.5 mM for
fragment 2 (Fig. 4); fragment 4 was too insoluble to
be measured. Surface complementarity42 analysis
has been used to quantify the fit of ligands to protein
pockets and is therefore useful in evaluating frag-
ment for suitability for further development. Such
analysis shows that fragment 2 has almost a perfect
score of 0.93 (on a scale of 0 to 1), and the other
fragments score between 0.35 and 0.58 consistent
with our biophysical data.Discussion
The enzymes of FAS II pathway are established
targets for antibacterial drugs, although recent works
suggest that their applicability may be limited to
Gram-negative organisms.8–10,14 Inhibitors have
been reported for FabZ from two organisms Helico-
bacter pylori and Plasmodium falciparum.10,15,16
Similar progress has not been reported for FabA
(the covalent configured 2-decenoyl-NAC cannot
adopt a configuration that matches the substrate),
yet FabA is a particularly attractive target since its
isomerization activity, which is essential, is not
possessed by FabZ (whereas FabA possesses the
dehydration activity of FabZ, potentially allowingFig. 5. Catalytic mechanism. (a) The common dehydration m
proton (orange) are abstracted from the same face according
shown. In PaFabZ, the equivalent residues occupy essentially i
right-hand side, the conformation of 3-hydroxydecanoyl-NAC
suprafacial elimination of water. W1 is shown as part of the hyd
the protonation state of Asp84 or it could take part in the shutt
FabA catalyzes the isomerization by extracting the pro-R pro
middle column are projections of the natural enzyme substrate
found in the structure does position the pro-R proton for abstr
bond (red). Thus, the complex serves as valid model for the se
which does not catalyze isomerization, the different protein str
thus preventing C5–C4–C3–C2 adopting the +60° configuratioFabA to compensate for loss of FabZ). The
discovery of binding fragments that occupy multiple
different positions in the PaFabA active site serves
as a starting point for inhibitor design (Fig. 3e).
Fragments 1 and 4 block the pantetheine-binding
tunnel and thus partly mimic the flavonoids and
synthetic inhibitors reported for HpFabZ15,17–19 (Fig.
S7b). However, in HpFabZ, both flavonoids and
synthetic inhibitors extend to a groove around the
pantetheine-binding tunnel; this groove does not
exist in PaFabA as it is filled by the side chain of the
conserved Arg104 (found also as lysine). Thus,
subtle differences in the pantetheine-binding tunnel
are reflected in the binding of inhibitors. Fragment 2
has some similarity with NAS91, 4-chloro-2-[(5-
chloroquinolin-8-yl)oxy]phenol, a competitive inhibi-
tor of PfFabZ, in that both contain two aromatic rings
link by an oxygen atom16 and both bind in a broadly
similar location. Unlike NAS91, however, fragment 2
does not interact with the catalytic residues. The
difference in binding observed between the two
compounds reflects the shift of the α3 helix between
the structures (Fig. S5). Fragment 3 is the first
compound reported that occupies the alkyl-binding
tunnel.
The substrate complex of PaFabA allows the
mechanism to be described in molecular detail
(Figs. 2c and 5a and b). His70 from one subunit is
positioned to abstract the proton from C2 while
Asp84 from the other subunit is directly hydrogenechanism of FabA and FabZ. Both the C3 hydroxyl and C2
to labeling studies. The catalytic residues for PaFabA are
dentical positions, although a Glu replaces the Asp. On the
found in the structure is shown and is consistent with the
rogen bond network around Asp84. It may assist in setting
ling of protons between this residue and the substrate. (b)
ton (purple) from C4 of its substrate. Shown boxed in the
. On the right, the conformation of 3-hydroxydecanoyl-NAC
action and would lead to a cis configuration of the C3–C4
cond reaction. The position of the C5 is critical. In PaFabZ,
ucture would result in clashes with C5 and C6 of substrate
n required to form a cis C3–C4 double bond.
373Mechanism of P. aeruginosa Protein Dehydratasebonded to the (R)-configured C3 hydroxyl, with a
water molecule (W1) involved in the network
(Fig. 2c). In an (S)-enantiomer, the hydroxyl would
point away from Asp84 (Fig. 5a), explaining the
stereoselectivity of the dehydration. Chemical rea-
soning implies that protonation of the hydroxyl would
be required for elimination; therefore, a proton must
be supplied by the protein. We suggest that the most
likely candidate is OD1 of Asp84, although a
protonated Asp would be unusual at physiological
pH. Asp84 sits in an extensive hydrogen bond
network involving W1 inside a hydrophobic active
site; we hypothesize that this could shift the effective
pKa but direct evidence is lacking. In this model, W1
does not arise from elimination from the substrate as
previously suggested5; rather, it plays a role in
mediating a complex network of hydrogen bonds
(W3 plays no role). The substrate dihedral angle C1–
C2–C3–C4 at 152° is very close to the expected
trans (180°) configuration of the resulting product; as
a result, the substrate is bound in a conformation
preset for E1cB-type elimination and formation of the
trans C2–C3 product. In this structural arrangement,
the net proton transfer (from C2 to the hydroxyl) is
suprafacial, in agreement with labeling studies on
the reverse reaction20 (Fig. 5a).
The second step, uniquely catalyzed by FabA, is
the isomerization of substrate from trans C2–C3 to
cis C3–C4. In FabA, the newly deprotonated Asp84
is 4.1 Å from C4 of the substrate mimic; thus, only a
small movement of the C4 atom would be needed for
Asp84 to deprotonate C4 (Fig. 5b), forming an allyl
anion. In the substrate mimic complex, the pro-R
hydrogen on the C4 atom points toward Asp84,
consistent with deuterium incorporation experiments
showing the pro-R, which is extracted.20 The
substrate mimic has a dihedral angle C2–C3–C4–
C5 of +60°. In the true substrate, this configuration
would result in the cis-configured C3–C4 double
bond (Fig. 5b) (upon quenching of the allyl anion by
protonation at C2). An alternate C2–C3–C4–C5
conformer (−60°) of the substrate mimic is not
possible in the active site, as it would result in C5
clashing with the catalytic Asp84 (or Glu63 in
PaFabZ). Even if such a clash could be accommo-
dated, the proton on C4 would be too far from the
carboxylate of Asp84 to be extracted. (The signifi-
cance of such a −60° configuration is that, in the
substrate, it would lead to a cis-configured C3–C4
double bond.) The third conformer (180° that leads to
a trans C3–C4) is impossible as it would result in
severe (interpenetrating) clashes of C6 and C7 with
α3 helix in both PaFabA (and PaFabZ).
An important question is why does PaFabZ not
catalyze the second isomerization step? The loca-
tion of C2 and C3 of the substrate will be the same in
both enzymes, their position determined by the
chemical requirement for proton transfer and dehy-
dration involving the conserved histidine and gluta-mic (aspartic) acid residues. As dehydration by
FabZ also gives the trans C2–C3 product, the C4
position is therefore expected to be located close to
the C4 position reported for the substrate mimic
complex. Superposition of the PaFabA complex with
PaFabZ shows that C1–C4 atoms of the substrate
mimic do not clash with the PaFabZ (Fig. 2d) and
are setup for catalysis. Our structural data identify
two key spatial considerations for isomerization.
Firstly, the C4 atom must be positioned such that the
catalytic carboxylic acid (Asp84) can abstract the
pro-R proton to form the allyl anion, and secondly,
the C5 atom must have enough space for the
substrate to adopt a dihedral C2–C3–C4–C5 angle
of +60°. The superposition of PaFabA complex with
PaFabZ structure shows that the C5 of substrate
would clash with the side chain of His13 of PaFabZ
(2.9 Å) and that C6 would clash with the backbone
carbonyl of Tyr87 (2.2 Å). These clashes would
prevent C5 in the substrate from adopting +60°
required for the cis configuration (the trans config-
uration would also be forbidden). The clashes result
from changes in the hydrophobic tunnel formed by
the loop connecting α1–β1 and the shift of β3. His13
is conserved in most FabZ (Asn in some lactoba-
cillales bacteria), whereas in FabA proteins, a
conserved proline (Pro29) is found in this position
(Fig. 2e). Single-site mutation EcFabZ-H13P or
EcFabA-P29H does not remove or confer isomeri-
zation activity.5 Domain swaps of two very closely
related Enterococcus faecalis proteins FabN (which
unusually has FabA-like activity despite being more
closely related to FabZ in sequence terms) and
FabZ6 identified a chimera capable of iso-
merization.6 In the active chimeric protein, β3–β4
from EfFabN was placed in EfFabZ. Single-site
mutants failed to achieve the same effect, consistent
with the complex structure showing that the main
chain at Tyr87 (located on β3 in PaFabZ), not simply
side chain at His 13, is involved in blocking C5 from
adopting the +60° configuration.Conclusion
FabA is a bifunctional enzyme and an attractive
antibiotic target for pathogenic Gram-negative or-
ganisms. By solving the structure of PaFabA in
complex with a substrate mimic, we have provided
molecular insight into the catalytic mechanism of this
enzyme. This new structure supports the hypothesis
that differences in the alkyl-binding site between
FabZ and FabA, rather than changes in catalytic
residues, are responsible for the fate of the substrate
in these enzymes. We have identified and described
four fragment complexes that may serve as starting
points for future inhibitor design. One fragment has
submillimolar affinity and appears a very good match
to the substrate-binding pocket.
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Materials
NAC, 4-dimethylaminopyridine and 3-ethyl-1-(3-
dimethylaminopropyl)carbodiimide hydrochloride were
purchased from Sigma-Aldrich; trans-2-decenoic acid
was from TCI, and (±)-3-hydroxydecanoic acid was from
Wako Chemicals.Synthesis of 3-hydroxydecanoyl-NAC thioester
The substrate analogue is synthesized using a pub-
lished procedure by coupling the corresponding carboxylic
acid with NAC.21,22
Cloning and purification of PaFabA
PaFabA was cloned with an N-terminal tobacco etch
virus protease cleavable His6-tag in pDEST14 vector using
a modified version of Gateway cloning system.23 Muta-
tions H70N, D84N and H70N D84N were constructed with
a modified protocol of the QuikChange method24,25 using
the primers 5′-TTC-GCC-TGT-AAC-TTC-GAA-GGC-GAT-
CCG-GTC-ATG and 5′-GAA-GTT-ACA-GGC-GAA-GAA-
CCA-CAG-GTC-CGG-GTT for H70N mutation and 5′-
GCC-TGA-ATG-CCA-TGT-GGC-AGC-TGG-TCG-GT and
5′-CAT-GGC-ATT-CAG-GCC-CAG-GCA-ACC-GGG-C
for D84N mutation. Mutations were confirmed by sequenc-
ing. Wild-type protein was over-expressed in E. coli Tuner
(DE3) cells. Cells were grown at 37 °C in LB medium
containing 100 μg ml−1 ampicillin until an OD600 of 0.6 was
reached and then induced with 0.4 mM IPTG at 15 °C
overnight. Mutant proteins were expressed in BL21 STAR
cells with autoinduction media25 at 20 °C for 48 h and
purified as the wild type. Harvested cells were re-
suspended in lysis buffer [20 mM NaHPO4 (pH 7.4),
10 mM imidazole and 500 mM NaCl] and incubated at
room temperature for 1 h with 100 μg ml−1 lysozyme and
20 μg ml−1 DNase. This was followed by two passes
through a cell disruptor (Constant Systems) and centrifu-
gation for 30 min at 75,500g. The supernatant was applied
to a charged HisTrap Nickel Sepharose, high-performance
column (GE Healthcare) (immobilized metal ion affinity
chromatography) and washed with lysis buffer containing
30 mM imidazole, and protein was eluted with lysis buffer
containing 300 mM imidazole. The imidazole was re-
moved by desalting chromatography before adding the
tobacco etch virus protease to cleave the His6-tag. Protein
was applied to a second immobilized metal ion affinity
chromatography column followed by Superdex S75 gel-
filtration chromatography (GE Healthcare) equilibrated
with 10 mM Tris (pH 7.5), 150 mMNaCl and 10% glycerol.
Protein fractions were pooled and concentrated to 8 mg
ml−1, purity was judged by SDS gels and the identity was
confirmed by mass spectrometry.
Identification of binding fragments by NMR
Binding fragments were identified by screening a May-
bridge Ro3 500 fragments library by saturated transferdifference and water logsy NMR techniques.26,27 The
soluble fragments with a clear spectrum (436) were
organized into 54 cocktails of 8 fragments and 1 cocktail
of 4 fragments such that spectra of individual compounds
could be identified. FabA was diluted to a final concentra-
tion of 20 μM in 50 mM sodium phosphate (pH 7.5), 10%
D2O and the fragment cocktail added to a final concentra-
tion of 1 mM. The total volume of the experiment was
750 μl. Using a Bruker Avance 500, we performed the two
NMR experiments sequentially on each sample. Data were
processed with Topspin 2 and AMIX to identify fragments
binding.
Crystallization and structure determination
Crystals of the wild-typePaFabA appeared at 20 °C after
2 days of incubation from a mixture of 1 μl of protein
solution (8 mg ml−1) with 1 μl of reservoir solution contain-
ing 18% polyethylene glycol (PEG) 3350, 0.12 M sodium
potassium phosphate, 6.4% hexanediol and 0.1 M sodium
citrate (pH 4.5) in a sitting-drop vapor diffusion experiment.
Crystals were cryoprotected by supplementing the mother
liquor with 15% glycerol. Prior to crystallization, 1 mM 3-
hydroxydecanoyl-NAC was incubated with the H70N
mutant at 8 mg ml−1 for 1 h and crystals appeared after
1 day by mixing 2 μl of protein solution with 1 μl of 13%
PEG monomethyl ether 5000, 0.1 M sodium citrate
(pH 4.5) and 0.09 M lithium sulfate again in a sitting-drop
vapor diffusion experiment. Co-crystallization and soaking
of fragments were conducted in two steps. The 49 hits were
arranged into cocktails of four fragments each at 12.5 mM.
Those that gave strong additional density either by soaking
or by co-crystallization were repeated with individual
compounds. Crystals of wild type with [5-(2-thienyl)-3-
isoxazolyl] methanol (fragment 1) and N-isobutyl-2-([5-(2-
thienyl)-1,2-oxazol-3-yl]methoxy)acetamide (fragment 4)
were obtained by co-crystallization under the same
condition as the 3-hydroxydecanoyl-NAC complex. Co-
crystals with 3-(pyridin-2-yloxy)aniline (fragment 2) were
obtained by mixing 2 μl of protein solution with 1 μl of the
reservoir solution with 15% PEG 8000, 0.2 M magnesium
chloride and 0.1 M Tris–HCl (pH 8.0). Crystals complexed
with 3-(pentylthio)-4H-1,2,4-triazole (fragment 3) were
obtained by soaking wild-type crystals for 20 min with
mother liquor containing 12.5 mM compound before
cryoprotection. Data were collected at beamlines ID29 at
the European Synchrotron Radiation Facility and IO2 and
IO4-1 at the Diamond Light Source Oxfordshire or in-house
using aRigakuMicromax™-007HFCu anodewith VariMax
optics and a Rigaku Saturn 944+ CCD detector. Data were
processed with HKL200028 or Xia2.29–33 The native
structure was solved using EcFabA as a model7 with the
program MOLREP.34 Complex structures were solved
using the coordinates of the wild-type PaFabA and the
program Phaser.35 PHENIX36 was used for autobuilding
from molecular replacement solutions. Models were
adjusted with Coot37 after each round of refinement in
REFMAC5.6 from the CCP4 program suite 6.2.0 with local
NCS restraints (option in program) and TLS parameters38
applied throughout for all structures. The native structure
contains 10 molecules in the asymmetric unit. One
molecule of glycerol and a phosphate ion are present in
each active site. Judging by average B-factor, subunits C,
E and G are the most well ordered. There are five
375Mechanism of P. aeruginosa Protein Dehydratasemolecules in the asymmetric unit of the 3-hydroxydeca-
noyl-NAC complex; one molecule of 3-hydroxydecanoyl-
NAC is present in each active site and was assigned an
occupancy of 1 (we did not have sufficient resolution to
confidently refine occupancy). The ligands in chains B and
C are in well-defined electron density. The ligand can be
modeled in the other monomers; however, the density is
less well defined. Co-complex crystals with fragments 1, 2
and 3 contain 20, 2 and 5 protein monomers in the
asymmetric unit, respectively. Again, each active site was
built with a fragment with occupancy of 1 as difference
density was visible in each. Chains D, F, J and N for
fragment 1; chain B for fragment 2; and chains B and E for
fragment 3 have the clearest density for the ligand. The
structure with fragment 4 contains five molecules in the
asymmetric unit but, only in chain B, was the electron
density clear enough to model a bound fragment (in the
pantetheine-binding tunnel). In chains A and E, there is
additional density at the active site, but we have been
unable to model this satisfactorily. Final refinement
statistics are given in Table 1. Atomic coordinates and
structure factors have been deposited in the Protein Data
Bank (4FQ9, 4B0I, 4B0J, 4B0B, 4B0C and 4B8U).
Coordinates and topologies of ligands were generated byTable 1. Crystallographic data and refinement statistics
PaFabA
H70N–3-OH-decanoyl-
NAC complex
Data collection
Space group C2 C2221
Cell dimensions
a, b, c (Å) 146.8, 135.8,
111.0
110.8, 169.7,
108.3
α, β, γ (°) 90, 108.8, 90 90, 90, 90 9
Resolution (Å)a 50–2.02
(2.07–2.02)
54–2.03
(2.15–2.03)
Rmerge 0.082 (0.477) 0.057 (0.457) 0
I/σ(I) 8.5 (2.3) 15.23 (2.7)
Completeness (%) 98.6 (98.3) 98.0 (99.5)
Average redundancy 3.2 (2.9) 4.5 (4.5)
Z′ 10 5
Refinement
Resolution (Å) 50–2.02 54–2.03
No. of reflections 126,685 61,486
Rwork/Rfree 0.19/0.21 0.17/0.20
No. of atoms
Protein 13,136 6490
Water molecules 721 355
Compound 122 95
B-factors (Å2)
Protein 35.6 53.9
Chain B range 30.8–41.9 51.4–61.2
Water 42.0 57.5
Compound 47.1 69.5
Compound B range 29.2–59.5 60.9–84.6
rmsd
Bond lengths (Å) 0.009 0.011
Bond angles (°) 1.49 1.275
Summary of the
Ramachandran
plots (%)b
98.51/1.49/0 98.20/1.68/0.12 9
The range of temperature factor is shown for the ligands within the as
a Numbers in parentheses represent statistics in highest-resolution
b Percentages of residues in the most favored regions/allowed regiPRODRG.39 The qualities of all structures were checked
with MolProbity.40 Figures were drawn using PyMOL.41
Enzyme assays
Activity was assessed by a spectrophotometry assay
based on the absorbance of the (E)-2-decenoyl-NAC at
260 nm.42 Briefly, 0.3 mM 3-hydroxydecanoyl-NAC was
solubilized in sodium phosphate (pH 7.5). The reaction is
started by adding 14 μg ml−1 of protein, and the increase
of the absorbance is monitored at 30 °C. This assay is not
suitable to assess the inhibition of the fragments because
they absorb at this wavelength.
Isothermal microcalorimetry titration
The affinities of ligands 1, 2 and 3 were measured by
isothermal titration calorimetry using a VP-ITC instrument
(GE Healthcare) at 20 °C. Titrations were performed using
37×7.5 μl injections of 30 mM fragment 1 in 55 μM
PaFabA or 4 mM fragment 2 in 32 μM proteins or
57×5 μl injections of the fragment 3 at 25 mM in 50 μM
PaFabA in the same buffer [100 mM sodium phosphateFragment 1
complex
Fragment 2
complex
Fragment 3
complex
Fragment 4
complex
P21 P21212 C2 C2
109.8, 108.2,
202.3
59.3, 118.0,
48.0
114.9, 141.7,
78.9
113.9, 143.7,
78.0
0, 103.13, 90 90, 90, 90 90, 115.7, 90 90, 116.5, 90
24–2.5
(2.54–2.5)
37–1.9
(1.95–1.9)
35–2.7
(2.77–2.7)
72–2.76
(2.83–2.76)
.109 (0.371) 0.106 (0.361) 0.044 (0.713) 0.081 (0.415)
13.6 (2.3) 14.9 (4.5) 16.8 (2.2) 7.5 (2.0)
96.9 (84.3) 99.0 (97.6) 99.2 (99.6) 96.8 (98.8)
3.4 (2.6) 7.8 (4.4) 3.9 (4.0) 3.0 (3.1)
20 2 5 5
24–2.5 37–1.90 35–2.7 72–2.76
147,156 25,582 29,525 26,426
0.23/0.26 0.20/0.23 0.20/0.23 0.18/0.22
25,965 2646 6494 6431
839 299 20 25
240 28 55 25
49.6 24.0 67.3 64.9
44.6–54.9 23.8–24.2 60.4–79.7 58.7–75.2
46.5 33.2 55.9 57.6
57.7 29.1 88.2 68.3
49.6–73.6 29.1–29.1 84.91–91.8 —
0.009 0.012 0.011 0.011
1.335 1.254 1.453 1.385
7.42/2.58/0.0 97.91/2.09/0 97.46/2.54/0 98.29/1.71/0
ymmetric unit (highest in structure to lowest in structure).
shell.
ons/disfavored regions.
376 Mechanism of P. aeruginosa Protein Dehydratase(pH 7.00) containing 10%dimethyl sulfoxide]. Experiments
were limited by the solubility of fragments, and the affinity of
fragment 4 cannot be estimated by this method. The heats
of dilution measured from injection of the ligands into the
buffer were subtracted from the experimental data, and
titration curves were fitted into a single-site binding using
the Origin software.
Acknowledgements
The research leading to these results has received
funding from the European Community's Seventh
Framework Programme (FP7/2007–2013) under
grant agreement number 223461.Supplementary Data
Supplementary data to this article can be found
online at http://dx.doi.org/10.1016/j.jmb.2012.11.017
Received 3 September 2012;
Received in revised form 12 November 2012;
Accepted 13 November 2012
Available online 19 November 2012
Keywords:
fatty acid biosynthesis;
β-hydroxydecanoyl-ACP dehydratase;
bacterial virulence
Abbreviations used:
ACP, acyl carrier protein; NAC, N-acetylcysteamine;
PEG, polyethylene glycol.References
1. White, S. W., Zheng, J., Zhang, Y. M. & Rock (2005).
The structural biology of type II fatty acid biosynthesis.
Annu. Rev. Biochem. 74, 791–831.
2. Cronan, J. E., Jr & Gelmann, E. P. (1975). Physical
properties of membrane lipids: biological relevance
and regulation. Bacteriol. Rev. 39, 232–256.
3. Hoang, T. T. & Schweizer, H. P. (1997). Fatty acid
biosynthesis in Pseudomonas aeruginosa: cloning
and characterization of the fabAB operon encoding
β-hydroxyacyl-acyl carrier protein dehydratase (FabA)
and β-ketoacyl-acyl carrier protein synthase I (FabB).
J. Bacteriol. 179, 5326–5332.
4. Zhu, K., Choi, K. H., Schweizer, H. P., Rock, C. O. &
Zhang, Y. M. (2006). Two aerobic pathways for the
formation of unsaturated fatty acids in Pseudomonas
aeruginosa. Mol. Microbiol. 60, 260–273.
5. Kimber, M. S., Martin, F., Lu, Y., Houston, S., Vedadi,
M., Dharamsi, A. et al. (2004). The structure of (3R)-
hydroxyacyl-acyl carrier protein dehydratase (FabZ)
from Pseudomonas aeruginosa. J. Biol. Chem. 279,
52593–52602.6. Lu, Y. J., White, S. W. & Rock, C. O. (2005).
Domain swapping between Enterococcus faecalis
FabN and FabZ proteins localizes the structural
determinants for isomerase activity. J. Biol. Chem.
280, 30342–30348.
7. Leesong, M., Henderson, B. S., Gillig, J. R., Schwab,
J. M. & Smith, J. L. (1996). Structure of a dehydratase-
isomerase from the bacterial pathway for biosynthesis
of unsaturated fatty acids: two catalytic activities in
one active site. Structure, 4, 253–264.
8. Campbell, J. W. & Cronan, J. E., Jr. (2001). Bacterial
fatty acid biosynthesis: targets for antibacterial drug
discovery. Annu. Rev. Microbiol. 55, 305–332.
9. Heath, R. J., White, S. W. & Rock, C. O. (2002).
Inhibitors of fatty acid synthesis as antimicrobial
chemotherapeutics. Appl. Microbiol. Biotechnol. 58,
695–703.
10. Parsons, J. B. & Rock, C. O. (2011). Is bacterial fatty
acid synthesis a valid target for antibacterial drug
discovery? Curr. Opin. Microbiol. 14, 544–549.
11. Rees, D. C., Congreve, M., Murray, C. W. & Carr, R.
(2004). Fragment-based lead discovery. Nat. Rev.,
Drug Discov. 3, 660–672.
12. Carr, R. A., Congreve, M., Murray, C. W. & Rees, D. C.
(2005). Fragment-based lead discovery: leads by
design. Drug Discovery Today, 10, 987–992.
13. Krissinel, E. & Henrick, K. (2007). Inference of macro-
molecular assemblies from crystalline state. J. Mol. Biol.
372, 774–797.
14. Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P.,
Gruss, A. & Poyart, C. (2009). Type II fatty acid
synthesis is not a suitable antibiotic target for Gram-
positive pathogens. Nature, 458, 83–86.
15. He, L., Zhang, L., Liu, X., Li, X., Zheng, M., Li, H.
et al. (2009). Discovering potent inhibitors against
the β-hydroxyacyl-acyl carrier protein dehydratase
(FabZ) of Helicobacter pylori: structure-based de-
sign, synthesis, bioassay, and crystal structure
determination. J. Med. Chem. 52, 2465–2481.
16. Maity, K., Venkata, B. S., Kapoor, N., Surolia, N.,
Surolia, A. & Suguna, K. (2011). Structural basis for
the functional and inhibitory mechanisms of β-hydro-
xyacyl-acyl carrier protein dehydratase (FabZ) of
Plasmodium falciparum. J. Struct. Biol. 176, 238–249.
17. Zhang, L., Liu, W., Hu, T., Du, L., Luo, C., Chen, K.
et al. (2008). Structural basis for catalytic and
inhibitory mechanisms of β-hydroxyacyl-acyl carrier
protein dehydratase (FabZ). J. Biol. Chem. 283,
5370–5379.
18. Zhang, L., Kong, Y., Wu, D., Zhang, H., Wu, J.,
Chen, J. et al. (2008). Three flavonoids targeting the
β-hydroxyacyl-acyl carrier protein dehydratase from
Helicobacter pylori: crystal structure characterization
with enzymatic inhibition assay. Protein Sci. 17,
1971–1978.
19. Kong, Y. H., Zhang, L., Yang, Z. Y., Han, C., Hu, L. H.,
Jiang, H. L. & Shen, X. (2008). Natural product juglone
targets three key enzymes from Helicobacter pylori:
inhibition assay with crystal structure characterization.
Acta Pharmacol. Sin. 29, 870–876.
20. Schwab, J. M. & Klassen, J. B. (1984). Steric course of
the allylic rearrangement catalyzed by β-hydroxyde-
canoylthioester dehydrase—mechanistic implica-
tions. J. Am. Chem. Soc. 106, 7217–7227.
377Mechanism of P. aeruginosa Protein Dehydratase21. Lapeyre, C., Delomenede, M., Bedos-Belval, F.,
Duran, H., Negre-Salvayre, A. & Baltas, M. (2005).
Design, synthesis, and evaluation of pharmacological
properties of cinnamic derivatives as antiatherogenic
agents. J. Med. Chem. 48, 8115–8124.
22. Kim, M. I., Kwon, S. J. & Dordick, J. S. (2009). In vitro
precursor-directed synthesis of polyketide analogues
with coenzyme a regeneration for the development of
antiangiogenic agents. Org. Lett. 11, 3806–3809.
23. Oke, M., Carter, L. G., Johnson, K. A., Liu, H.,
McMahon, S. A., Yan, X. et al. (2010). The Scottish
Structural Proteomics Facility: targets, methods and
outputs. J. Struct. Funct. Genomics, 11, 167–180.
24. Liu, H. & Naismith, J. H. (2008). An efficient one-step
site-directed deletion, insertion, single and multiple-
site plasmid mutagenesis protocol. BMC Biotechnol.
8, 91.
25. Studier, F. W. (2005). Protein production by auto-
induction in high density shaking cultures. Protein
Expression Purif. 41, 207–234.
26. Meyer, B. & Peters, T. (2003). NMR spectroscopy
techniques for screening and identifying ligand bind-
ing to protein receptors. Angew. Chem. 42, 864–890.
27. Dalvit, C., Pevarello, P., Tato, M., Veronesi,M., Vulpetti,
A. & Sundstrom, M. (2000). Identification of compounds
with binding affinity to proteins via magnetization
transfer from bulk water. J. Biomol. NMR, 18, 65–68.
28. Otwinowski, Z. & Minor, W. (1997). Processing of
X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 276, 307–326.
29. Winter, G. (2010). Xia2: an expert system for macro-
molecular crystallography data reduction. J. Appl.
Crystallogr. 43, 186–190.
30. Zhang, Z., Sauter, N. K., van den Bedem, H., Snell, G.
& Deacon, A. M. (2006). Automated diffraction image
analysis and spot searching for high-throughput
crystal screening. J. Appl. Crystallogr. 39, 112–119.
31. Sauter, N. K., Grosse-Kunstleve, R.W. &Adams, P. D.
(2004). Robust indexing for automatic data collection.
J. Appl. Crystallogr. 37, 399–409.32. Kabsch, W. (1993). Automatic processing of rotation
diffraction data from crystals of initially unknown
symmetry and cell constants. J. Appl. Crystallogr.
26, 795–800.
33. Evans, P. (2006). Scaling and assessment of data
quality. Acta Crystallogr., Sect. D: Biol. Crystallogr. 62,
72–82.
34. Vagin, A. & Teplyakov, A. (1997). MOLREP: an
automated program for molecular replacement. J. Appl.
Crystallogr. 30, 1022–1025.
35. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D.,
Winn, M. D., Storoni, L. C. & Read, R. J. (2007).
Phaser crystallographic software. J. Appl. Crystallogr.
40, 658–674.
36. Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen,
V. B., Davis, I. W., Echols, N. et al. (2010).
PHENIX: a comprehensive Python-based system
for macromolecular structure solution. Acta Crystal-
logr., Sect. D: Biol. Crystallogr. 66, 213–221.
37. Emsley, P. & Cowtan, K. (2004). Coot: model-building
tools for molecular graphics. Acta Crystallogr., Sect.
D: Biol. Crystallogr. 60, 2126–2132.
38. Murshudov, G. N., Vagin, A. A. & Dodson, E. J.
(1997). Refinement of macromolecular structures by
the maximum-likelihood method. Acta Crystallogr.,
Sect. D: Biol. Crystallogr. 53, 240–255.
39. Schuttelkopf, A. W. & van Aalten, D. M. (2004).
PRODRG: a tool for high-throughput crystallography
of protein–ligand complexes. Acta Crystallogr., Sect.
D: Biol. Crystallogr. 60, 1355–1363.
40. Chen, V. B., Arendall, W. B., 3rd, Headd, J. J., Keedy,
D. A., Immormino, R. M., Kapral, G. J. et al. (2010).
MolProbity: all-atom structure validation for macromo-
lecular crystallography. Acta Crystallogr., Sect. D:
Biol. Crystallogr. 66, 12–21.
41. Schrodinger, LLC. (2010). The PyMOL Molecular
Graphics System, Version 1.3r1.
42. Kass, L. R. (1969). β-Hydroxydecanoyl thioester
dehydrase from Escherichia coli. Methods Enzymol.
14, 73–80.
